Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Animal Health, Inc. on May 18, 2015. The report documents corporate governance actions taken in connection with the closing of the Company's initial public offering (IPO).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on legal and corporate structural changes rather than financial performance data.
Material Changes
- Corporate Charter: The Company filed an amended and restated certificate of incorporation with the Delaware Secretary of State, effective upon the IPO closing.
- Bylaws: The Company adopted amended and restated bylaws, also effective upon the IPO closing.
- Approval: Both the Restated Certificate and Restated Bylaws were previously approved by the board of directors and stockholders.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on operations, specific risks, contingencies, or unusual items. The document serves strictly to disclose the adoption of new corporate governance documents.
Key Facts for Investor Verification
- Verify the closing date and terms of the IPO referenced in the Registration Statement on Form S-1 (File No. 333-198383).
- Review the attached Exhibit 3.1 (Second Amended and Restated Certificate of Incorporation) for changes to authorized share capital or director structure.
- Review the attached Exhibit 3.2 (Bylaws) for changes to meeting procedures or voting rights.
- Confirm the Company's legal name change from "Jaguar Animal Health, Inc." to "Jaguar Health, Inc." if applicable in subsequent filings.